image
Aclarion, Inc. ACONW
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
Watchlist
$ 0.0725
14.4 %
$ 3.4 M
Market Cap
-0.01
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Mar, 1, 2025.

The intrinsic value of one ACONW stock under the worst case scenario is HIDDEN Compared to the current market price of 0.0725 USD, Aclarion, Inc. is HIDDEN

ACONW Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Mar, 1, 2025.

The intrinsic value of one ACONW stock under the base case scenario is HIDDEN Compared to the current market price of 0.0725 USD, Aclarion, Inc. is HIDDEN

ACONW Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Mar, 1, 2025.

The intrinsic value of one ACONW stock under the best case scenario is HIDDEN Compared to the current market price of 0.0725 USD, Aclarion, Inc. is HIDDEN

ACONW Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart ACONW

image
1M 40%
6M 86%
1Y 45%
3Y --%
5Y --%
All
$0.1$0.1$0.1$0.1$0.1$0.1$0.1$0.1$0.0$0.0$0.0$0.0$0.0$0.0Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25
FINANCIALS
75.4 K REVENUE
24.75%
Growth Rates
1Year 24.75%
3Years 15.73%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-4.88 M OPERATING INCOME
20.05%
Growth Rates
1Year 20.05%
3Years -2.88%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-4.91 M NET INCOME
35.42%
Growth Rates
1Year 35.42%
3Years -1.95%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-3.65 M OPERATING CASH FLOW
31.37%
Growth Rates
1Year 31.37%
3Years 1.32%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-120 K INVESTING CASH FLOW
42.50%
Growth Rates
1Year 42.50%
3Years 12.60%
5Years 0.00%
7Years 0.00%
10Years 0.00%
3.31 M FINANCING CASH FLOW
-49.41%
Growth Rates
1Year -49.41%
3Years -4.96%
5Years 0.00%
7Years 0.00%
10Years 0.00%
14.4 K REVENUE
31.32%
Growth Rates
1Year 24.75%
3Years 15.73%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-1.3 M OPERATING INCOME
-14.12%
Growth Rates
1Year 20.05%
3Years -2.88%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-1.37 M NET INCOME
-10.35%
Growth Rates
1Year 35.42%
3Years -1.95%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-1.06 M OPERATING CASH FLOW
-0.11%
Growth Rates
1Year 31.37%
3Years 1.32%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-104 K INVESTING CASH FLOW
-10.47%
Growth Rates
1Year 42.50%
3Years 12.60%
5Years 0.00%
7Years 0.00%
10Years 0.00%
1.3 M FINANCING CASH FLOW
589.15%
Growth Rates
1Year -49.41%
3Years -4.96%
5Years 0.00%
7Years 0.00%
10Years 0.00%
Balance Sheet Aclarion, Inc.
image
Current Assets 1.29 M
Cash & Short-Term Investments 1.02 M
Receivables 13.4 K
Other Current Assets 255 K
Non-Current Assets 1.17 M
Long-Term Investments 0
PP&E 1.78 K
Other Non-Current Assets 1.17 M
41.51 %10.36 %47.51 %Total Assets$2.5m
Current Liabilities 3.19 M
Accounts Payable 761 K
Short-Term Debt 1.13 M
Other Current Liabilities 1.3 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0
23.86 %35.31 %40.83 %Total Liabilities$3.2m
EFFICIENCY
Earnings Waterfall Aclarion, Inc.
image
Revenue 75.4 K
Cost Of Revenue 75.7 K
Gross Profit -324
Operating Expenses 4.88 M
Operating Income -4.88 M
Other Expenses 35.4 K
Net Income -4.91 M
500k500k00(500k)(500k)(1m)(1m)(1m)(1m)(2m)(2m)(2m)(2m)(3m)(3m)(3m)(3m)(4m)(4m)(4m)(4m)(5m)(5m)75k(76k)(324)(5m)(5m)(35k)(5m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
-0.43% GROSS MARGIN
-0.43%
Averages
1Year -0.43%
3Years -7.73%
5Years -38.85%
7Years 0.00%
10Years 0.00%
-6466.48% OPERATING MARGIN
-6466.48%
Averages
1Year -6466.48%
3Years -7151.30%
5Years -9115.59%
7Years 0.00%
10Years 0.00%
-6513.41% NET MARGIN
-6513.41%
Averages
1Year -6513.41%
3Years -9150.20%
5Years -10451.59%
7Years 0.00%
10Years 0.00%
674.64% ROE
674.64%
Averages
1Year 674.64%
3Years 75.55%
5Years 106.15%
7Years 0.00%
10Years 0.00%
-199.67% ROA
-199.67%
Averages
1Year -199.67%
3Years -223.65%
5Years -264.62%
7Years 0.00%
10Years 0.00%
-1225.96% ROIC
-1225.96%
Averages
1Year -1225.96%
3Years -526.03%
5Years -228.22%
7Years 0.00%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Aclarion, Inc.
image
00(1m)(1m)(2m)(2m)(3m)(3m)(4m)(4m)(5m)(5m)(6m)(6m)20202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Net Income -4.91 M
Depreciation & Amortization 163 K
Capital Expenditures -120 K
Stock-Based Compensation 456 K
Change in Working Capital 623 K
Others 427 K
Free Cash Flow -3.77 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Aclarion, Inc.
image
ACONW has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 3 of 2
6. Ownership
Insider Ownership Aclarion, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
8. Profile Summary

Aclarion, Inc. ACONW

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 3.4 M
Dividend Yield 0.00%
Description Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Contact 951 Mariners Island Boulevard, San Mateo, CA, 94404 https://www.aclarion.com
IPO Date None
Employees 4
Officers Mr. John Lorbiecki Chief Financial Officer Dr. Jeffrey John Thramann M.D. Executive Chairman Mr. Ryan Bond Chief Strategy Officer Mr. Brent Ness Chief Executive Officer, President & Director